G. Michael Wall
Geen lopende functies
Profiel
G.
Michael Wall worked as a Vice President-Product Development at Otonomy, Inc. before pursuing his education.
He holds a graduate degree from Auburn University and a doctorate from the University of Mississippi.
Eerdere bekende functies van G. Michael Wall
| Bedrijven | Functie | Einde |
|---|---|---|
| OTONOMY | Corporate Officer/Principal | - |
Opleiding van G. Michael Wall
| University of Mississippi | Doctorate Degree |
| Auburn University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
